Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

Recruiting NCT05643157

Cellular Scale Measures of Short-Term Retinal Atrophy Progression

Conditions: Pentosan Polysulfate Sodium Maculopathy, Pigmentary Maculopathy, Toxic Maculopathy, Pigmentary Retinopathy, Interstitial Cystitis, Chronic

Sex: All

Ages: 18 Years – 70 Years

Enrollment: 10

Sponsor: Indiana University

Location: United States

Summary

Our goal is to determine the cellular scale changes that occur in subjects who have disease progression due to pentosan polysulfate sodium toxicity

Eligibility Criteria

Inclusion Criteria:A history of pentosan polysulfate sodium (Elmiron) usage for 5+ yearsDocumented retinal findings that are associated with pentosan polysulfate sodium toxicityExclusion Criteria:Presence of cataract or ocular media opacity that impedes retinal imagingIf standard pupil dilation imposes a risk to ocular healthDocumented severe dry eye on ocular examHigh refractive error (more than -/+ 6 Diopters)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05643157). StuddyBuddy aggregates publicly available trial information.